Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C

By Norton P.M.   Wells J.M.   Brown H.W.G.   Macpherson A.M.   Le Page R.W.F.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 616-619

Elsevier

Access to resources Recommend Favorite

Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice

By Jabbal-Gill I.   Fisher A.N.   Rappuoli R.   Davis S.S.   Illum L.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 2039-2046

Elsevier

Access to resources Recommend Favorite

Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant

By Isaka M.   Yasuda Y.   Taniguchi T.   Kozuka S.   Matano K.   Maeyama J.-i.   Morokuma K.   Ohkuma K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1165-1173

Elsevier

Access to resources Recommend Favorite

Are DNA-based vaccines useful for protection against secreted bacterial toxins? Tetanus toxin test case

By Saikh K.U.   Sesno J.   Brandler P.   Ulrich R.G.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 1029-1038

Elsevier

Access to resources Recommend Favorite

Intranasal or subcutaneous co-administration of recombinant cholera toxin B subunit stimulates only a slight or no level of the specific IgE response in mice to tetanus toxoid

By Isaka M.   Yasuda Y.   Kozuka S.   Taniguchi T.   Miura Y.   Matano K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 944-948

Elsevier

Access to resources Recommend Favorite